论文部分内容阅读
《柳叶刀》(2005;366:45562)杂志上所发表的一篇研究发现,药物阿那曲唑(anastrozole,瑞宁得,Arimidex)在抑制乳腺癌复发方面要较他莫昔芬更加有效。他莫昔芬为当前治疗激素反应性乳腺癌的一线药物。奥地利和德国的研究人员对3200例接受两年他莫昔芬治疗的绝经后妇女进行了研究,
A study published in The Lancet (2005; 366: 45562) found that the drug anastrozole (Arimidex) is more effective than tamoxifen in inhibiting breast cancer recurrence. Tamoxifen is currently the first-line drug for hormone-responsive breast cancer. Researchers from Austria and Germany studied 3,200 postmenopausal women who had received two years of tamoxifen treatment,